ad image

Charcot-Marie-Tooth Association

1 / 1
Vanda Pharmaceuticals
Announcement

Vanda Pharmaceuticals Announces the Publication of an Article "Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"

Vanda Pharmaceuticals

PR-02-25-NI-25Feb 24, 2025
Regenacy Pharmaceuticals
Collaboration

Regenacy Pharmaceuticals Announces Collaboration with the Charcot-Marie-Tooth Association (CMTA) to Advance Ricolinostat for the Treatment of Hereditary Neuropathy

Regenacy Pharmaceuticals

PR-M08-18-NI-044Aug 13, 2018
1 / 1